Mitochondrial Dysfunction

R&D

Partner Content

Uncover mitochondrial pathogenic mechanisms to show clinical efficacy for regulatory success

Events

Partner Content

Therapies for mitochondrial dysfunction

News

Aspen Neuroscience and Bambusa Therapeutics get their Nasdaq IPOs over the line, while Corxel eyes a debut via a blank-cheque company merger.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.